Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial
Age and Ageing · 2024
DOI: 10.1093/ageing/afae133 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Age and Ageing, 2024. Verfasst von Jonathan M K Bogaerts und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Primary Care, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Nursing Homes, Quality of Life, Dementia, Antihypertensive Agents. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organisation for Health Research and Development, Leiden University Medical Center.
Themen: Langzeitpflege, Demenz
Abstract (Originalsprache)
Background
Based on observational studies and randomised controlled trials (RCTs), the benefit–harm balance of antihypertensive treatment in older adults with dementia is unclear.
Objective
To assess whether discontinuing antihypertensive treatment reduces neuropsychiatric symptoms (NPSs) and maintains quality of life (QoL) in nursing home residents with dementia.
Design
Open-label, blinded-outcome RCT. Randomisation 1:1, stratified by nursing home organisation and baseline NPS.
Trial registration
NL7365. Subjects Dutch long-term care residents with moderate-to-severe dementia and systolic blood pressure (SBP) ≤160 mmHg during antihypertensive treatment. Exclusion criteria included heart failure NYHA-class-III/IV, recent cardiovascular events/procedures or life expectancy <4 months (planned sample size n = 492).
Measurements
Co-primary outcomes NPS (Neuropsychiatric Inventory-Nursing Home [NPI-NH]) and QoL (Qualidem) at 16 weeks.
Results
From 9 November 2018 to 4 May 2021, 205 participants (median age 85.8 [IQR 79.6–89.5] years; 79.5% female; median SBP 134 [IQR 123–146] mmHg) were randomised to either antihypertensive treatment discontinuation (n = 101) or usual care (n = 104). Safety concerns, combined with lacking benefits, prompted the data safety and monitoring board to advice a premature cessation of randomisation. At 16-week follow-up, no significant differences were found between groups for NPI-NH (adjusted mean difference 1.6 [95% CI –2.3 to 5.6]; P = 0.42) or Qualidem (adjusted mean difference − 2.5 [95% CI –6.0 to 1.0]; P = 0.15). Serious adverse events (SAEs) occurred in 36% (discontinuation) and 24% (usual care) of the participants (adjusted hazard ratio 1.65 [95% CI 0.98–2.79]). All 32-week outcomes favoured usual care.
Conclusion
Halfway through this study, a non-significant increased SAE risk associated with discontinuing antihypertensive treatment was observed, and an associated interim analysis showed that significant worthwhile health gain for discontinuation of antihypertensive treatment was unlikely. This unbeneficial benefit–harm balance shows that discontinuation of antihypertensive treatment in this context does not appear to be either safe or beneficial enough to be recommended in older adults with dementia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Primary Care, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
- LUMC Center for Medicine for Older People, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
- Department of Internal Medicine, Section Gerontology and Geriatrics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
- Department of Clinical Epidemiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
- Department of Biomedical Datasciences, Section Medical Statistics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
- Department of Psychiatry, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
ORCID-Profile: Jonathan M K Bogaerts, Simon P Mooijaart, Wilco P Achterberg
Förderung
- Netherlands Organisation for Health Research and Development
- Leiden University Medical Center
Zitieren
APA
Bogaerts, J. M. K., Gussekloo, J., de Jong-Schmit, B. E. M., Le Cessie, S., Mooijaart, S. P., van der Mast, R. C., Achterberg, W. P., & Poortvliet, R. K. E. (2024). Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial. Age and Ageing. https://doi.org/10.1093/ageing/afae133
Vancouver
Bogaerts JMK, Gussekloo J, de Jong-Schmit BEM, Le Cessie S, Mooijaart SP, van der Mast RC, et al. Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial. Age and Ageing. 2024. doi:10.1093/ageing/afae133
BibTeX
@article{Bogaerts2024,
author = {Bogaerts, Jonathan M K and Gussekloo, Jacobijn and de Jong-Schmit, Bianca E M and Le Cessie, Saskia and Mooijaart, Simon P and van der Mast, Roos C and Achterberg, Wilco P and Poortvliet, Rosalinde K E},
title = {Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial},
journal = {Age and Ageing},
year = {2024},
doi = {10.1093/ageing/afae133}
}
EUVIMED